199 related articles for article (PubMed ID: 31627216)
21. Recent Change in Treatment of Disseminated Intravascular Coagulation in Japan: An Epidemiological Study Based on a National Administrative Database.
Murata A; Okamoto K; Mayumi T; Muramatsu K; Matsuda S
Clin Appl Thromb Hemost; 2016 Jan; 22(1):21-7. PubMed ID: 25736054
[TBL] [Abstract][Full Text] [Related]
22. Treatments and outcomes of neonatal disseminated intravascular coagulation with and without neonatal asphyxia: A retrospective study using nationwide data in Japan.
Kitaoka H; Konishi T; Shitara Y; Ito A; Kashima K; Hashimoto Y; Matsui H; Kato M; Takahashi N; Yasunaga H
Pediatr Neonatol; 2024 Mar; 65(2):117-122. PubMed ID: 37659900
[TBL] [Abstract][Full Text] [Related]
23. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
24. The effect of antithrombin added to recombinant human-soluble thrombomodulin for severe community-acquired pneumonia-associated disseminated intravascular coagulation: a retrospective cohort study using a nationwide inpatient database.
Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H
J Intensive Care; 2020; 8():8. PubMed ID: 31956416
[TBL] [Abstract][Full Text] [Related]
25. Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
Hayakawa M; Yamakawa K; Kudo D; Ono K
Clin Appl Thromb Hemost; 2018 Sep; 24(6):874-883. PubMed ID: 29514467
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Vincent JL; Ramesh MK; Ernest D; LaRosa SP; Pachl J; Aikawa N; Hoste E; Levy H; Hirman J; Levi M; Daga M; Kutsogiannis DJ; Crowther M; Bernard GR; Devriendt J; Puigserver JV; Blanzaco DU; Esmon CT; Parrillo JE; Guzzi L; Henderson SJ; Pothirat C; Mehta P; Fareed J; Talwar D; Tsuruta K; Gorelick KJ; Osawa Y; Kaul I
Crit Care Med; 2013 Sep; 41(9):2069-79. PubMed ID: 23979365
[TBL] [Abstract][Full Text] [Related]
27. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
[TBL] [Abstract][Full Text] [Related]
28. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
Nagafuchi H; Eguchi Y; Ikeda T
Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
[TBL] [Abstract][Full Text] [Related]
29. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
[TBL] [Abstract][Full Text] [Related]
31. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
32. Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
Wada T; Yamakawa K; Kabata D; Abe T; Ogura H; Shiraishi A; Saitoh D; Kushimoto S; Fujishima S; Mayumi T; Hifumi T; Shiino Y; Nakada TA; Tarui T; Otomo Y; Okamoto K; Umemura Y; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S; Gando S
Sci Rep; 2022 Jun; 12(1):9304. PubMed ID: 35660774
[TBL] [Abstract][Full Text] [Related]
33. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
[TBL] [Abstract][Full Text] [Related]
34. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
[TBL] [Abstract][Full Text] [Related]
35. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan.
Iwasaki Y; Ohbe H; Shigemi D; Fushimi K; Yasunaga H
BJOG; 2022 Apr; 129(5):805-811. PubMed ID: 34545675
[TBL] [Abstract][Full Text] [Related]
36. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
Levi M
Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
[No Abstract] [Full Text] [Related]
37. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers.
Tagami T; Matsui H; Yasunaga H
J Thromb Haemost; 2015 Apr; 13(4):686-8. PubMed ID: 25650788
[No Abstract] [Full Text] [Related]
38. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
Wada H; Aota T; Matsumoto T; Suzuki K; Imai H; Katayama N
J Thromb Haemost; 2015 Apr; 13(4):684-5. PubMed ID: 25611679
[No Abstract] [Full Text] [Related]
39. Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers.
Iba T
J Thromb Haemost; 2015 Apr; 13(4):682-3. PubMed ID: 25611174
[No Abstract] [Full Text] [Related]
40. Anticoagulation Therapy Using rh-Thrombomodulin and/or Antithrombin III Agent is Associated With Reduction in in-Hospital Mortality in Septic Disseminated Intravascular Coagulation: A Nationwide Registry Study.
Tanaka K; Takeba J; Matsumoto H; Ohshita M; Annen S; Moriyama N; Nakabayashi Y; Aibiki M
Shock; 2019 Jun; 51(6):713-717. PubMed ID: 31090683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
